CBUS
Cibus, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.59
−2.45%Next report
Analyst consensus
- Next report date
- Nov 12, 2026
- EPS estimate
- -$0.20
- Revenue estimate
- $1.3M
Latest reported
- Last report date
- Aug 13, 2026
- EPS actual
- -$0.29
- EPS estimate
- -$0.19
- Revenue actual
- $994.0K
- Revenue estimate
- $1.7M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 3
- EPS misses (12Q)
- 9
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -18.3%
- Revenue beats (12Q)
- 6
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 13, 2026 | -$0.19 | -$0.29 | Miss -52.63% | $994.0K |
| May 14, 2026 | -$0.35 | -$0.33 | Beat 5.71% | $1.7M |
| Mar 17, 2026 | -$0.35 | -$0.42 | Miss -19.15% | $1.1M |
| Nov 13, 2025 | -$0.41 | -$0.44 | Miss -7.32% | $615.0K |
| Aug 14, 2025 | -$0.69 | -$0.61 | Beat 11.59% | $933.0K |
| May 8, 2025 | -$0.70 | -$0.74 | Miss -5.71% | $1.0M |
| Mar 20, 2025 | -$0.68 | -$0.87 | Miss -27.94% | $1.2M |
| Nov 7, 2024 | -$0.90 | $0.06 | Beat 106.67% | $1.7M |
| Aug 8, 2024 | -$0.81 | -$1.14 | Miss -40.74% | $838.0K |
| May 9, 2024 | -$1.01 | -$1.12 | Miss -10.89% | $545.0K |
| Mar 21, 2024 | -$1.12 | -$1.16 | Miss -3.57% | $1.1M |
| Nov 9, 2023 | -$1.18 | -$1.59 | Miss -34.75% | $475.0K |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 12, 2026